THERAPEUTIC EFFECT OF N-(4-HYDROXYPHENYL) RETINAMIDE (4-HPR) ON METHYLNITROSOUREA (MNU) INDUCED RAT MAMMARY-CANCER

被引：0
|
作者：
DOWLATSHAHI, K
MEHTA, R
THOMAS, CF
DINGER, NM
MOON, R
机构：
[1] UNIV CHICAGO,CHICAGO,IL 60637
[2] IIT,RES INST,CHICAGO,IL 60616
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1988年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [21] Separation and isolation of metabolites of N-(4-hydroxyphenyl) retinamide (4-HPR) after incubation with Sprague-Dawley rat liver microsomes
    Malcolm, Emily K.
    Kelley, Melissa D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 756 - 756
  • [22] N-(4-hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species
    Goto, H
    Takahashi, H
    Fujii, H
    Ikuta, K
    Yokota, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (03) : 219 - 225
  • [23] N-(4-Hydroxyphenyl)retinamide (4-HPR) Induces Leukemia Cell Death via Generation of Reactive Oxygen Species
    Hiroaki Goto
    Hiroyuki Takahashi
    Hisaki Fujii
    Koichiro Ikuta
    Shumpei Yokota
    International Journal of Hematology, 2003, 78 : 219 - 225
  • [24] THE EFFECT OF N-(4-HYDROXYPHENYL) RETINAMIDE (HPR FENRETINIDE) ON PLASMA RETINOL KINETICS IN RATS
    ADAMS, WR
    GREEN, MH
    SMITH, JE
    GREEN, JB
    FASEB JOURNAL, 1992, 6 (05): : A1783 - A1783
  • [25] Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus
    Martin, Alexander J.
    Shackleford, David M.
    Charman, Susan A.
    Wagstaff, Kylie M.
    Porter, Christopher J. H.
    Jans, David A.
    PHARMACEUTICS, 2023, 15 (07)
  • [26] IMPORTANCE OF SYSTEMIC METABOLISM IN THE MODULATION OF SKIN TUMOR-INDUCTION IN MICE BY THE RETINOID N-(4-HYDROXYPHENYL)-RETINAMIDE (4-HPR)
    MCCORMICK, DL
    BAGG, BJ
    HULTIN, TA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 145 - 145
  • [27] Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis
    Abou-Issa, H
    Curley, RW
    Alshafie, GA
    Weiss, KL
    Clagett-Dame, M
    Chapman, JS
    Mershon, SM
    ANTICANCER RESEARCH, 2001, 21 (6A) : 3839 - 3844
  • [28] Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells
    Mehta, RR
    Hawthorne, ME
    Graves, JM
    Mehta, RG
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) : 902 - 907
  • [29] DISPOSITION AND METABOLISM OF N-(4-METHOXYPHENYL)RETINAMIDE (MPR), THE MAJOR METABOLITE OF N-(4-HYDROXYPHENYL)RETINAMIDE (HPR), IN MICE
    HULTIN, TA
    FILLA, MS
    MCCORMICK, DL
    FASEB JOURNAL, 1988, 2 (05): : A1095 - A1095
  • [30] SUPPRESSION OF RAT MAMMARY-CANCER DEVELOPMENT BY N-(4-HYDROXY-PHENYL)RETINAMIDE (4-HPR) FOLLOWING SURGICAL REMOVAL OF 1ST PALPABLE TUMOR
    MOON, RC
    PRITCHARD, JF
    MEHTA, RG
    NOMIDES, CT
    THOMAS, CF
    DINGER, NM
    CARCINOGENESIS, 1989, 10 (09) : 1645 - 1649
12345